Inpatient Hematology / Oncology
- Adult Leukemia
- Non-Malignant Hematology
Ambulatory Hematology / Oncology Clinics
- Central Nervous System
- Multiple Myeloma
- Non-Malignant Hematology
- Thoracic, Head & Neck
Oncology Clinical Practice Operation
- Chemotherapy Verification / Sterile Compounding
ELECTIVE ROTATION (OFF-SITE) – 4 WEEKS
- Inpatient Stem Cell Transplant / CAR-T
*Required discussion with program director and the availability of the rotation site.
PRACTICE MANAGEMENT (ONCOLOGY FOCUS)
- Medication Safety
- Formulary Management
- Pharmacy Informatics
- Financial Patient Assistance Process
- Medication Use Evaluation
PRESENTATIONS AND TEACHING OPPORTUNITIES
- Oncology Topic Discussions (Lunch and Learn)
- Journal Club and Case Presentations
- Nursing Inservices
- Layered Teaching Learning Opportunities (PGY1 residents and APPE students)
The resident will provide clinical oncology operations support which includes chemotherapy order entry and verification, as well as chemotherapy preparation and checking. The resident will be assigned to work 12-15 weekends, including Thanksgiving or Christmas, and 1-2 minor holidays.
Frequently Asked Questions
What are the program's admission requirements?
Individuals wishing to apply to the Harris Health Residency Program must:
- Be a graduate of an ACPE-accredited College of Pharmacy
- Have current valid pharmacy license in the state of Texas, or be eligible for licensure
- Completion of a ASHP accredited Postgraduate Year One Residency Program
- Enroll in the Residency Matching Program
- Submit application materials through the Pharmacy Online Residency Centralized Application Service (PhORCAS) System by December 31, 2022
Can Harris Health sponsor applicants with visas?
Harris Health cannot sponsor student work visas.
What is Harris Health System’s Oncology Postgraduate Year Two Program ASHP Accreditation Status?
The Postgraduate Year Two Oncology program conducted by Harris Health System in Houston, TX has a pre-candidate accreditation status with ASHP. However, our world class oncology / hematology care preceptor team has provided guidance and stewardship in the specialized practice of oncology / hematology pharmacotherapy to ASHP accredited Postgraduate Year One Program and Postgraduate Year Two Administration program residents for 15 years.
What documents are required for program application?
Applications shall be deemed complete upon the receipt of the following:
- Curriculum Vitae
- Letter of Interest
- Describe your reasons for pursuing a PGY2 Oncology residency. The letter should include details about your professional interests, achievements, and your five-year goals as a pharmacist.
- Official Transcripts
- Official transcripts related to pharmacy education are required
- Three (3) Letters of Recommendation
- Reference writers must complete the standardized reference form in the PhORCAS system.
- One letter of recommendation must be from a pharmacist who has supervised you or an APPE preceptor.
What is the official start date of the program?
The official start date of the program is July 3, 2023.
When is the application deadline?
All PHORCAS application documents must be received by December 31, 2022.
How can I apply for this residency program?
Application materials shall be submitted via the PhORCAS System.
Can the program extend beyond the 12 months of Residency Class?
Residents will not be allowed to extend the program with or without pay beyond the allotted 12 months of Resident year.
For additional information, please contact:
Residency Program Director
Pharmacy Supervisor, Integrated Pharmacy Services
Residency Program Coordinator
PGY2 Health-System Pharmacy Administration and Leadership Resident
Chief Pharmacy Resident